Descriptions:
| Term | description type | Language/acceptability | Language/acceptability | Case significance |
|---|---|---|---|---|
| Product containing [substance] in [pharmaceutical dose form] (medicinal product form) | FSN | us:P | gb:P | ci |
| [substance]-containing product in [pharmaceutical dose form] | SYN | us:P | gb:P | ci |
Concept model:
| Attribute cardinality | Attribute | Value | role group number | role group cardinality |
|---|---|---|---|---|
| 1..1 | 0 | N/A | ||
| 1..1 | 0 | 1..* | ||
| 1..1 | 0 | 1..1 |
Definition status:
Rules for description generation:
- Apply General rules for generating descriptions for templates
- 'and [substance]' needs to be added for FSN for multiple |has active ingredient| and they are self grouped, e.g. Product containing calcium carbonate and light kaolin in oral dose form (medicinal product form)
- '[substance]- and' needs at the beginning of the description to be added for PT for multiple |has active ingredient| and they are self grouped, e.g. calcium carbonate- and light kaolin-containing product in oral dose form
- For multiple ingredients, the ingredients in each description need to be in alphabetical order e.g. Codeine and paracetamol for FSN but Acetaminophen and codeine (for US PT).
JIRA ticket for implementation:
DRUGS-275 - Getting issue details... STATUS
INFRA-3052 - Getting issue details... STATUS
DRUGS-643 - Getting issue details... STATUS